Fengjin Zhou

Fengjin Zhou

Auto-generated profile, based on publicly available information

Fengjin Zhou

Department of Orthopaedics, Honghui Hospital, Xi’an Jiao Tong University, Xi’an, China

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 November 2024 in Journal of Nanobiotechnology
Verified
Journal Article
Open access
PDF file
GZGuangyin Zhou
Guangyin Zhou
RLRuiyang Li
Ruiyang Li
SSShihao Sheng
Shihao Sheng
JHJingtao Huang
Jingtao Huang
FZFengjin Zhou
Fengjin Zhou
JSJiacan Su
Jiacan Su
Organoids are “mini-organs” that self-organize and differentiate from stem cells under in vitro 3D culture conditions, mimicking the spatial structure and function of tissues in vivo. Extracellular vesicles (EVs) are nanoscale phospholipid bilayer vesicles secreted by living cells, rich in bioactive molecules, with excellent biocompatibility and low immunogenicity. Compared to EVs, organoid-derived EVs (OEVs) exhibit higher yield and enhanced biological functions. Organoids possess stem cell characteristics, and OEVs are capable of delivering active substances, making both highly promising for medical applications. In this review, we provide an overview of the fundamental biological principles of organoids and OEVs, and discuss their current applications in disease treatment. We then focus on the differences between OEVs and traditional EVs. Subsequently, we present methods for the engineering modification of OEVs. Finally, we critically summarize the advantages and challenges of organoids and OEVs. In conclusion, we believe that a deeper understanding of organoids and OEVs will provide innovative solutions to complex diseases.